Transfection reagents are primarily used for introducing nucleic acids into cells in order to study gene functions and expressions. Moreover, transfection reagents find widespread use in gene therapy development process owing to their ability to deliver genetic materials into targeted cells. Growing demand for gene therapies to treat various illnesses such as cancer and genetic disorders is expected to drive the global transfection reagents and equipment market.

The global Transfection Reagents and Equipment Market is estimated to be valued at US$ 1342.78 Bn in 2023 and is expected to exhibit a CAGR of 8.4% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
Use of advanced technologies such as microfluidics and electroporation is one of the key trends being witnessed in the global transfection reagents and equipment market. Microfluidic-based transfection platforms enable high-throughput screening of various genes by delivering nucleic acids into cells through fluidic channels. On the other hand, electroporation involves using electric fields to reversibly make the cell membrane permeable, allowing nucleic acids to pass into the cells. These advanced transfection methods are more efficient than traditional chemical and viral-based methods. Growing research in gene therapies has increased the demand for efficient and reliable nucleic acid delivery methods using advanced technologies. This is expected to drive the adoption of microfluidics and electroporation in transfection over the forecast period.

Segment Analysis
Transfection reagents dominated the global transfection reagents and equipment market in 2024. The segment held around 70% share owing to increasing demand for transfection reagents in gene therapy, vaccinology research and transgenic model research. The transfection reagents are extensively used during process of transformation of cells to introduce genetic material like DNA or RNA. The reagents allow genes to enter targeted cell types and produce desired therapeutic proteins. The reagents also find widespread application in discovery and development of novel biologics.

Key Takeaways
The Global Transfection Reagents And Equipment Market Size is expected to witness high growth during the forecast period of 2024 to 2031. The market is driven by rising investment in gene therapy and vaccination research. The global Transfection Reagents and Equipment Market is estimated to be valued at US$ 1342.78 Bn in 2023 and is expected to exhibit a CAGR of 8.4% over the forecast period 2024 to 2031.

Regional analysis
North America dominated the global transfection reagents and equipment market in 2024 and is expected to continue its dominance during the forecast period. Presence of major players and availability of developed research infrastructure are major factors contributing to large share of North America. Asia Pacific is expected to witness fastest growth during the forecast period supported by increasing research investment in China and India.

Key players
Key players operating in the transfection reagents market includes Nestle Waters, PepsiCo, Inc., The Coca-Cola Company, Groupe Danone, Suntory Beverage & Food Ltd. These players are focusing on new product launches and regional expansion to gain higher market shares. For instance, Nestle Waters launched new product variants of bottled water with mineral compositions optimized for specific health benefits.

Get more insights on this topic:
https://www.dailyprbulletin.com/transfection-reagents-and-equipment-market-share/